Brief: Autolus Therapeutics Announces Resignation Of Chief Financial Officer
14/03/2023 11:17
March 14 (Reuters) - Autolus Therapeutics PLC AUTL.O :
* AUTOLUS THERAPEUTICS ANNOUNCES RESIGNATION OF CHIEF
FINANCIAL
OFFICER
* AUTOLUS THERAPEUTICS PLC - DR. LUCINDA CRABTREE TO STEP
DOWN
WITH EFFECT FROM Q3 2023
* AUTOLUS THERAPEUTICS PLC - SEARCH FOR NEW CFO HAS BEEN
INITIATED
* AUTOLUS THERAPEUTICS PLC - CFO LUCINDA CRABTREE TO STEP
DOWN
WITH EFFECT FROM Q3 2023
Source text for Eikon: ID:nGNX3FV5Kv
Further company coverage: AUTL.O
((Reuters.Briefs@thomsonreuters.com;;))
Recent news on Autolus Therapeutics
See all newsBrief: Autolus Therapeutics PLC Unit Enters Master Service Agreement With AGC Biologics
Brief: Autolus Therapeutics Appoints Ryan Richardson To Board Of Directors
Brief: Nice Recommends Aucatzyl As A Treatment Option For Adult Patients With Lymphoblastic Leukemia
Brief: Autolus Therapeutics’ Car T Therapy Aucatzyl® (Obecabtagene Autoleucel) Granted European Marketing Authorization For Adult Patients
Brief: Autolus Therapeutics Announces Inducement Grants